ConductScience.org, home

Paper33467005

Rational Design of CYP3A4 Inhibitors: A One-Atom Linker Elongation in Ritonavir-Like Compounds Leads to a Marked Improvement in the Binding Strength.

Samuels ER and 1 other. Int J Mol Sci, 2021. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Rational Design of CYP3A4 Inhibitors: A One-Atom Linker Elongation in Ritonavir-Like Compounds Leads to a Marked Improvement in the Binding Strength. Papers, record 33467005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33467005

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rational Design of CYP3A4 Inhibitors: A One-Atom Linker Elongation in Ritonavir-Like Compounds Leads to a Marked Improvement in the Binding Strength.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.22
iCite
Revised in PubMed
2021-04-07
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Samuels EREric R
2Sevrioukova IFIrina Fhttps://orcid.org/0000-0002-4498-6057

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytochrome P-450 CYP3AMajor topic
Cytochrome P-450 CYP3A InhibitorsMajor topic
RitonavirMajor topic
Binding Sites
Drug Design
Humans
Molecular Docking Simulation
Protein Binding
Quantitative Structure-Activity Relationship

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 GM124169NIGMS NIH HHSUnited StatesP30GM124169PubMed and NIHNIH RePORTER
P30 GM133894NIGMS NIH HHSUnited StatesP30GM133894PubMed and NIHNIH RePORTER
R01 ES025767NIEHS NIH HHSUnited StatesR01ES025767PubMed and NIHNIH RePORTER
ES025767NIH HHSUnited StatesR01ES025767PubMed and NIHNIH RePORTER

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119649922Pharmacokinetic enhancers for HIV drugs.Curr Opin Investig Drugs2009https://conductscience.org/library/papers/19649922PubMed
21912325Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes.Chem Res Toxicol1991https://conductscience.org/library/papers/1912325PubMed
326239522Evidence-based choice of ritonavir as index CYP3A inhibitor in drug-drug interaction studies.J Clin Pharmacol2016https://conductscience.org/library/papers/26239522PubMed
48759309Metabolism of organochlorine pesticides: the role of human cytochrome P450 3A4.Chemosphere1996https://conductscience.org/library/papers/8759309PubMed
520937904Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20937904PubMed
67708670ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7708670PubMed
720124702PHENIX: a comprehensive Python-based system for macromolecular structure solution.Acta Crystallogr D Biol Crystallogr2010https://conductscience.org/library/papers/20124702PubMed
828590129High-Level Production and Properties of the Cysteine-Depleted Cytochrome P450 3A4.Biochemistry2017https://conductscience.org/library/papers/28590129PubMed
99616191
Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir.
Drug Metab Dispos1998https://conductscience.org/library/papers/9616191PubMed
1025846301Ritonavir-boosted protease inhibitor based therapy: a new strategy in chronic hepatitis C therapy.Expert Rev Gastroenterol Hepatol2015https://conductscience.org/library/papers/25846301PubMed
1130912932Structure-Activity Relationships of Rationally Designed Ritonavir Analogues: Impact of Side-Group Stereochemistry, Headgroup Spacing, and Backbone Composition on the Interaction with CYP3A4.Biochemistry2019https://conductscience.org/library/papers/30912932PubMed
1232435378Targeting Orthosteric and Allosteric Pockets of Aromatase via Dual-Mode Novel Azole Inhibitors.ACS Med Chem Lett2020https://conductscience.org/library/papers/32435378PubMed
1328124606Cytochrome P450 Structure, Function and Clinical Significance: A Review.Curr Drug Targets2018https://conductscience.org/library/papers/28124606PubMed
1427128223The ketoconazole legacy.Clin Pharmacol Drug Dev2014https://conductscience.org/library/papers/27128223PubMed
1532044230An increase in side-group hydrophobicity largely improves the potency of ritonavir-like inhibitors of CYP3A4.Bioorg Med Chem2020https://conductscience.org/library/papers/32044230PubMed
1610952482Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole.Eur J Clin Pharmacol2000https://conductscience.org/library/papers/10952482PubMed
1728118711Design, Synthesis, and Structure-Activity Relationship of New Pyrimidinamine Derivatives Containing an Aryloxy Pyridine Moiety.J Agric Food Chem2017https://conductscience.org/library/papers/28118711PubMed
1830140110Direct Synthesis of α-Thio Aromatic Acids from Aromatic Amino Acids.Tetrahedron Lett2018https://conductscience.org/library/papers/30140110PubMed
1928488354Cooperative Light-Activated Iodine and Photoredox Catalysis for the Amination of Csp3 -H Bonds.Angew Chem Int Ed Engl2017https://conductscience.org/library/papers/28488354PubMed
209516219Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.N Engl J Med1998https://conductscience.org/library/papers/9516219PubMed

See all 42 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
41608248Reformulation of the protein databank for real-time search of geometrical attributes of protein structures.Front Mol Biosci2025https://conductscience.org/library/papers/41608248PubMed
39792691Evaluation of Larger Side-Group Functionalities and the Side/End-Group Interplay in Ritonavir-Like Inhibitors of CYP3A4.Chem Biol Drug Des2025https://conductscience.org/library/papers/39792691PubMed
38992454Synthesis and anticancer properties of a hybrid molecule with the testosterone and estradiol head-groups.Steroids2024https://conductscience.org/library/papers/38992454PubMed
36848848Investigating a new C2-symmetric testosterone dimer and its dihydrotestosterone analog: Synthesis, antiproliferative activity on prostate cancer cell lines and interaction with CYP3A4.Eur J Med Chem2023https://conductscience.org/library/papers/36848848PubMed
36293445Crystal Structure of CYP3A4 Complexed with Fluorol Identifies the Substrate Access Channel as a High-Affinity Ligand Binding Site.Int J Mol Sci2022https://conductscience.org/library/papers/36293445PubMed
36077379Silibinin Suppresses the Hyperlipidemic Effects of the ALK-Tyrosine Kinase Inhibitor Lorlatinib in Hepatic Cells.Int J Mol Sci2022https://conductscience.org/library/papers/36077379PubMed
36077262The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?Int J Mol Sci2022https://conductscience.org/library/papers/36077262PubMed
35934190Artemisia extracts differ from artemisinin effects on human hepatic CYP450s 2B6 and 3A4 in vitro.J Ethnopharmacol2022https://conductscience.org/library/papers/35934190PubMed
35806297Interaction of CYP3A4 with Rationally Designed Ritonavir Analogues: Impact of Steric Constraints Imposed on the Heme-Ligating Group and the End-Pyridine Attachment.Int J Mol Sci2022https://conductscience.org/library/papers/35806297PubMed
34684008Improving Curcumin Bioavailability: Current Strategies and Future Perspectives.Pharmaceutics2021https://conductscience.org/library/papers/34684008PubMed
34110801Photosensitive Ru(II) Complexes as Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4.J Am Chem Soc2021https://conductscience.org/library/papers/34110801PubMed
34072457Structural Basis for the Diminished Ligand Binding and Catalytic Ability of Human Fetal-Specific CYP3A7.Int J Mol Sci2021https://conductscience.org/library/papers/34072457PubMed
33933755Innovative C2-symmetric testosterone and androstenedione dimers: Design, synthesis, biological evaluation on prostate cancer cell lines and binding study to recombinant CYP3A4.Eur J Med Chem2021https://conductscience.org/library/papers/33933755PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYB5A1528PubTator's text mininghttps://conductscience.org/library/genes/1528NCBI Gene
CYP2B61555PubTator's text mininghttps://conductscience.org/library/genes/1555NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33467005

GET https://conductscience.org/api/papers/v1/33467005/references?page=2